Replimune (REPL) EBITDA (2017 - 2026)
Replimune (REPL) posted EBITDA of -$54.87 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$82.88 million a year earlier.
Powered by 
Analysis
Replimune (REPL) EBITDA (2017 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, EBITDA at Replimune was -$264.04 million; for FY2026 (ended Mar 31, 2026), it was -$314.16 million.
- In prior fiscal years, Replimune's EBITDA was -$255.7 million in FY2025, -$232.07 million in FY2024, -$174.63 million in FY2023 and -$116.17 million in FY2022.
- The fiscal Q2 2027 figure stands as the highest quarterly EBITDA since fiscal Q4 2023.
- According to Business Quant data, EBITDA for the three prior fiscal quarters was -$66.7 million (Q1 2027), -$72 million (Q4 2026) and -$70.46 million (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 13.33 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 7.37 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Replimune | 2.40 Bn | 1.35 Bn | - | -54.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -54.87 Mn |
| Jun 30, 2026 | -66.70 Mn |
| Mar 31, 2026 | -72.00 Mn |
| Dec 31, 2025 | -70.46 Mn |
| Sep 30, 2025 | -82.88 Mn |
| Jun 30, 2025 | -88.92 Mn |
| Mar 31, 2025 | -77.92 Mn |
| Dec 31, 2024 | -64.41 Mn |
| Sep 30, 2024 | -57.41 Mn |
| Jun 30, 2024 | -56.02 Mn |
| Mar 31, 2024 | -58.06 Mn |
| Dec 31, 2023 | -55.84 Mn |
| Sep 30, 2023 | -63.13 Mn |
| Jun 30, 2023 | -55.03 Mn |
| Mar 31, 2023 | -52.47 Mn |
| Dec 31, 2022 | -40.95 Mn |
| Sep 30, 2022 | -40.96 Mn |
| Jun 30, 2022 | -40.26 Mn |
| Mar 31, 2022 | -31.44 Mn |
| Dec 31, 2021 | -29.15 Mn |
API Access
Replimune EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();